DX-2930-03, HELP Studie
Laufzeit: 01.01.2016 - 31.12.2017
Laufzeit: 01.01.2016 - 31.12.2017
HELP Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX-2930 for Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
Prevention of HAE attacks with s.c. prophylaxis